top of page

Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB

  • 16. Mai 2019
  • 1 Min. Lesezeit

May 16, 2019

Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.




 
 

Ähnliche Beiträge

Alle ansehen
bottom of page